In a study evaluating matched synovial tissue and psoriatic skin samples from individuals with psoriatic arthritis (PsA) and plaque psoriasis, IL-20 expression was found to correlate positively with disease activity, as measured by the PASI, both at the baseline and after therapeutic intervention with alefacept [55]. This evidence concerns the gene IL20 and psoriatic arthritis.